Radioisotopes

 

The portfolio of ITG radioisotopes and generators utilized in the ITM Group has been carefully selected and developed to comply with a set of narrow and challenging specifications.

The ITM radioisotope production and supply systems are optimized to meet the quality and supply standards (interuption free, security of supply) required in a dynamically developing environment of a new generation of targeted, personalized therapies.

All radioisotope related production and logistics services are provided by ITG Isotope Technologies Garching GmbH ("ITG") a wholly owned subsidiary of ITM AG:

ITG has development projects on variety of radioisotopes Lu-177 n.c.a., Re-188 and Ac-225/Bi-213.


For further information please refer to:


This e-mail address is being protected from spambots. You need JavaScript enabled to view it


 

News

ITG has received the Manufacturing License for Lu-177 n.c.a.

As of December 2011, ITG Isotope Technologies Garching GmbH has successfully passed the audit of the GMP production of the...
Read more...

ITG Isotope Technologies Garching GmbH (Germany) announces broad collaboration with ANSTO (Australia) on radioisotopes

Garching, Germany, June 3, 2011. ITG Isotope Technologies Garching GmbH (ITG), a specialist in the development and production of innovative...
Read more...

Helmholtz Zentrum München and ITM AG enter antibody deal

Ascenion has mediated a license agreement between the Helmholtz Zentrum München and ITM Isotopen Technologien München AG providing the company...
Read more...